Alnylam Pharmaceuticals, Inc. and Glaxosmithkline Plc.– Major Players in RNAi Therapeutics Market RNAi refers to the interference RNA which is responsible to control and manipulate protein translation in the cell. These RNAi are used to silence particular genes which are responsible for diseases. Currently, the awareness about RNAi is increasing extensively due to its ability to offer target specific mechanism, leading to superior treatment outcomes. The approach is widely utilized for drug...
0 Acciones
1236 Views
0 Vista previa